Given its crucial role in regulating airway inflammation, the inhibition of the PI3K/Akt signaling pathway through targeted molecules that modulate Th1/Th2 responses has been shown to mitigate the pathological changes associated with asthma and contribute significantly to airway protection [32]. The gene discussed is AKT1; the disease is asthma.